How to Value a Healthcare Staffing Business in 2026

Healthcare staffing is not general staffing. I've watched sellers make this mistake repeatedly — they look at general staffing multiples (3-5x EBITDA) and assume that's their market. It isn't. Healthcare staffing commands meaningfully higher multiples because of licensing requirements, credentialing complexity, structural demand tailwinds, and margin profiles that general staffing companies can't touch.

Across 37 healthcare staffing transactions in our database, the median EBITDA multiple is 9.2x and the median revenue multiple is 0.91x. In the $5-25M enterprise value range, EBITDA multiples cluster around 5.75x. The sector is growing, consolidation is active, and the post-COVID normalization has created a more sustainable — and arguably more attractive — acquisition landscape than the frothy 2021-2022 period.

The Three Segments: Completely Different Economics

Healthcare staffing breaks into three primary segments, and they have fundamentally different margin structures, growth dynamics, and valuation profiles. Buyers evaluate each one differently.

Travel Nursing: High Margin, High Volatility

Travel nursing generated the most M&A attention during COVID and the most confusion since. During 2021-2022, travel nurse bill rates hit $150-250/hour (compared to pre-COVID norms of $65-90/hour), and margins expanded to 25-35%. Companies that had $5M in revenue in 2019 were suddenly doing $25M with unprecedented margins. Multiples compressed, though, because every sophisticated buyer knew the revenue was unsustainable.

By 2026, the market has normalized. Bill rates have settled at $75-110/hour for most specialties — higher than pre-COVID but well off the peaks. Margins have compressed to 18-25%, which is still attractive relative to general staffing (12-18%). The normalization has actually made travel nursing companies more valuable on a sustainable basis because buyers can now underwrite forward revenue with confidence.

What drives travel nursing valuation:

• Gross margin per discipline: Buyers model margin by specialty (ICU, OR, L&D, ER) and geography. Specialty nursing margins (OR, NICU) run 3-5% higher than med-surg, and that adds up across hundreds of placements.
• Nurse retention and redeployment rate: What percentage of your nurses take another assignment with you after their current contract ends? Industry average is 50-60%. Companies above 70% redeployment rate command premium multiples because they've solved the most expensive problem in the business — recruiting.
• Hospital system relationships: Direct MSA (Master Services Agreement) contracts with health systems are far more valuable than subcontracting through VMSs (Vendor Management Systems). Direct contracts mean higher margins and stronger relationships.
• Technology platform: Companies with proprietary credentialing, scheduling, and compliance platforms are more efficient and more attractive to buyers. Manual, spreadsheet-driven operations signal scalability problems.

Travel nursing companies with $10M+ revenue, normalized margins above 20%, and strong redeployment rates are trading at 7-10x normalized EBITDA. The emphasis is on "normalized" — buyers will adjust for COVID-era anomalies and value you on sustainable earnings.

Per Diem Staffing: Steady and Undervalued

Per diem healthcare staffing — filling daily shifts at local hospitals and facilities — is the workhorse of the industry. Less glamorous than travel, lower margins (15-22%), but remarkably steady. Hospitals always need shift coverage, and the demand is non-cyclical.

I actually think per diem companies are undervalued relative to travel. The revenue is more predictable (driven by ongoing hospital staffing needs rather than crisis surges), the nurse pool is local (lower housing and travel costs), and client relationships tend to be deeper because you're embedded in the hospital's daily operations.

Per diem companies with strong fill rates (85%+ of requested shifts filled) and deep relationships with 3-5 major hospital systems in a metro area are trading at 5-7x EBITDA. The key metric buyers focus on is fill rate — it measures both your nurse supply depth and your operational efficiency.

Permanent Placement: Highest Revenue Per Transaction

Permanent placement (direct hire) for healthcare professionals — physicians, nurse practitioners, specialized therapists — generates the highest revenue per placement ($15-40K for nurses, $25-50K for physicians) but is the hardest to scale and most volatile quarter to quarter.

Valuation for perm placement firms is lower than travel or per diem because of the revenue lumpiness and the lack of recurring revenue. Each placement is a one-time transaction. Multiples: 3-5x EBITDA for pure perm firms, rising to 5-7x for companies that have built a mix of perm and contract staffing.

The most valuable perm placement firms are those with exclusive or preferred relationships with health systems for hard-to-fill specialties (psychiatry, rural primary care, hospitalist programs). These relationships take years to build and represent genuine competitive advantages.

The Barriers That Create Value

Healthcare staffing commands premium multiples over general staffing because of genuine barriers to entry that most outsiders underestimate.

State licensing and credentialing. Healthcare staffing agencies must hold licenses in every state where they place clinicians. Each state has different requirements — some require physical offices, bonding, or specific insurance minimums. The credentialing process for each nurse (license verification, background checks, drug screening, skills assessments, facility-specific orientation) is a 2-6 week process that requires dedicated compliance staff. A general staffing firm can't just decide to start placing nurses.

Joint Commission certification. While not legally required, Joint Commission certification for staffing companies is effectively a prerequisite for working with major health systems. The certification process evaluates your credentialing, competency assessment, and compliance systems. It's expensive and time-consuming to achieve, and it signals quality to hospital clients.

Clinical compliance infrastructure. Healthcare staffing companies carry significant compliance burden — managing licensure across states, maintaining clinical competency records, managing liability insurance at clinician-specific levels, and ensuring HIPAA compliance. This infrastructure represents a real investment that barriers entry and protects margins.

Post-COVID Normalization: What It Means for Sellers

The 2021-2022 period was an anomaly that distorted both revenue and valuation expectations. I've spent considerable time helping healthcare staffing owners recalibrate their expectations for the normalized market.

The good news: demand remains structurally strong. Nursing shortages are projected to worsen through 2030 as baby boomer retirements accelerate and nursing school capacity remains constrained. Hospital systems have accepted that agency staffing is a permanent part of their labor model, not a temporary crisis measure.

The adjustment: margins have come down from crisis levels, and buyers are underwriting based on 2024-2026 performance, not 2021-2022. If your business grew 300% during COVID and has since contracted 50%, buyers will value you on the current run rate — not the peak and not the average. The sellers who accept this reality and present their business on normalized metrics close deals faster and at better terms than those still anchored to peak-year EBITDA.

Who's Buying Healthcare Staffing Companies

The buyer landscape is active and diverse:

Large staffing platforms (AMN Healthcare, Cross Country, Aya Healthcare, Medical Solutions) acquire to expand geographic coverage, add specialties, or gain technology capabilities. They typically pay 7-10x EBITDA for meaningful platforms ($20M+ revenue) with differentiated positions.

PE-backed platforms are building through buy-and-build in healthcare staffing, often starting with a platform acquisition at 7-9x and adding bolt-ons at 4-6x. KKR's investment in Aya Healthcare and Olympus Partners' backing of Medical Solutions demonstrate the PE appetite for the sector.

Health system-affiliated staffing entities are an emerging buyer category. Several large health systems have created internal staffing companies and are acquiring external agencies to build self-sufficient clinician supply chains.

Maximizing Your Exit Value

If you're running a healthcare staffing company and considering a sale in the next 1-3 years:

Diversify beyond travel nursing. Companies with a mix of travel, per diem, and allied health placements are valued higher than pure travel shops because of reduced revenue concentration risk. Adding therapy (PT, OT, SLP) or allied health (radiology, respiratory) disciplines broadens your addressable market and smooths revenue volatility.

Build direct health system relationships. Reduce dependence on VMS/MSP intermediaries. Direct contracts mean higher margins and stronger competitive positioning. Even converting 3-5 relationships from VMS to direct over 12-18 months can meaningfully improve your margin profile and attractiveness to acquirers.

Invest in your credentialing and compliance platform. Buyers will diligence your credentialing files extensively. Clean, complete credential files for every active clinician — with no gaps in licensure, certifications, or competency assessments — signal operational maturity. Deficiencies here can delay or kill transactions.

Focus on redeployment rate. Every nurse you redeploy to a new assignment without re-recruiting saves $3-5K in recruitment costs. Improving redeployment from 55% to 70% doesn't just improve current margins — it signals to buyers that your nurses prefer working for you, which is the strongest indicator of sustainable competitive advantage in staffing.

The Bottom Line

Healthcare staffing is a structurally attractive industry with strong demand tailwinds, meaningful barriers to entry, and an active acquirer universe. The post-COVID normalization has been painful for some owners who grew accustomed to crisis-level margins, but it has created a more rational market where quality operators are being fairly valued. The companies that will command the highest multiples are those with diversified service lines, direct health system relationships, strong nurse retention, and clean compliance infrastructure. Those four pillars matter more than top-line revenue growth in today's market.